CN108872614B - 用于从维生素d结合蛋白解离维生素d的溶液、相关的检测方法及用途 - Google Patents
用于从维生素d结合蛋白解离维生素d的溶液、相关的检测方法及用途 Download PDFInfo
- Publication number
- CN108872614B CN108872614B CN201810816766.5A CN201810816766A CN108872614B CN 108872614 B CN108872614 B CN 108872614B CN 201810816766 A CN201810816766 A CN 201810816766A CN 108872614 B CN108872614 B CN 108872614B
- Authority
- CN
- China
- Prior art keywords
- vitamin
- detection
- surfactant
- volume
- buffer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000011710 vitamin D Substances 0.000 title claims abstract description 104
- 229940046008 vitamin d Drugs 0.000 title claims abstract description 104
- 229930003316 Vitamin D Natural products 0.000 title claims abstract description 101
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 title claims abstract description 101
- 235000019166 vitamin D Nutrition 0.000 title claims abstract description 101
- 150000003710 vitamin D derivatives Chemical class 0.000 title claims abstract description 101
- 238000001514 detection method Methods 0.000 title claims abstract description 41
- 102000050760 Vitamin D-binding protein Human genes 0.000 title claims abstract description 16
- 101710179590 Vitamin D-binding protein Proteins 0.000 title claims abstract description 16
- 238000010494 dissociation reaction Methods 0.000 title abstract description 73
- 230000005593 dissociations Effects 0.000 title abstract description 73
- 239000004094 surface-active agent Substances 0.000 claims abstract description 62
- 238000000034 method Methods 0.000 claims abstract description 41
- 239000002207 metabolite Substances 0.000 claims abstract description 40
- 125000003709 fluoroalkyl group Chemical group 0.000 claims abstract description 36
- 238000011002 quantification Methods 0.000 claims abstract description 28
- 239000012472 biological sample Substances 0.000 claims abstract description 7
- 238000000338 in vitro Methods 0.000 claims abstract description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 57
- 239000000523 sample Substances 0.000 claims description 32
- 230000027455 binding Effects 0.000 claims description 28
- 239000000872 buffer Substances 0.000 claims description 24
- KQNSPSCVNXCGHK-UHFFFAOYSA-N [3-(4-tert-butylphenoxy)phenyl]methanamine Chemical compound C1=CC(C(C)(C)C)=CC=C1OC1=CC=CC(CN)=C1 KQNSPSCVNXCGHK-UHFFFAOYSA-N 0.000 claims description 17
- 238000003018 immunoassay Methods 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 11
- JWUBBDSIWDLEOM-XHQRYOPUSA-N (3e)-3-[(2e)-2-[1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol Chemical compound C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2\C1=C\C=C1/CC(O)CCC1=C JWUBBDSIWDLEOM-XHQRYOPUSA-N 0.000 claims description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000007787 solid Substances 0.000 claims description 10
- 239000007853 buffer solution Substances 0.000 claims description 9
- 235000021318 Calcifediol Nutrition 0.000 claims description 8
- SNGREZUHAYWORS-UHFFFAOYSA-N perfluorooctanoic acid Chemical compound OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F SNGREZUHAYWORS-UHFFFAOYSA-N 0.000 claims description 8
- 210000002966 serum Anatomy 0.000 claims description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 239000007790 solid phase Substances 0.000 claims description 5
- JWUBBDSIWDLEOM-NQZHSCJISA-N 25-hydroxy-3 epi cholecalciferol Chemical compound C1([C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=CC=C1C[C@H](O)CCC1=C JWUBBDSIWDLEOM-NQZHSCJISA-N 0.000 claims description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 4
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 claims description 4
- 229920001400 block copolymer Polymers 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 150000002170 ethers Chemical class 0.000 claims description 3
- 210000002381 plasma Anatomy 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 229920000136 polysorbate Polymers 0.000 claims description 3
- 229940068965 polysorbates Drugs 0.000 claims description 3
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 claims description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 2
- GUVUOGQBMYCBQP-UHFFFAOYSA-N dmpu Chemical compound CN1CCCN(C)C1=O GUVUOGQBMYCBQP-UHFFFAOYSA-N 0.000 claims description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims description 2
- ZWBAMYVPMDSJGQ-UHFFFAOYSA-N perfluoroheptanoic acid Chemical compound OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F ZWBAMYVPMDSJGQ-UHFFFAOYSA-N 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 48
- 125000004432 carbon atom Chemical group C* 0.000 abstract description 10
- 239000000243 solution Substances 0.000 description 71
- 239000012491 analyte Substances 0.000 description 34
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 20
- 239000002953 phosphate buffered saline Substances 0.000 description 20
- 238000003556 assay Methods 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000007983 Tris buffer Substances 0.000 description 12
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 239000003446 ligand Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 230000001900 immune effect Effects 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- 239000000700 radioactive tracer Substances 0.000 description 7
- 239000000427 antigen Substances 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 108091007433 antigens Proteins 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 125000005010 perfluoroalkyl group Chemical group 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 239000011653 vitamin D2 Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000004949 mass spectrometry Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- PXUULQAPEKKVAH-UHFFFAOYSA-N perfluorohexanoic acid Chemical compound OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F PXUULQAPEKKVAH-UHFFFAOYSA-N 0.000 description 4
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 4
- GMRQFYUYWCNGIN-ZVUFCXRFSA-N 1,25-dihydroxy vitamin D3 Chemical compound C1([C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=CC=C1C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-ZVUFCXRFSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
- 102000014914 Carrier Proteins Human genes 0.000 description 3
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 3
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 3
- -1 Perfluorohexanoic acid (perfluorohexanoic acid) Chemical compound 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 230000003167 anti-vitamin Effects 0.000 description 3
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- HSHNITRMYYLLCV-UHFFFAOYSA-N 4-methylumbelliferone Chemical compound C1=C(O)C=CC2=C1OC(=O)C=C2C HSHNITRMYYLLCV-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000008100 Human Serum Albumin Human genes 0.000 description 2
- 108091006905 Human Serum Albumin Proteins 0.000 description 2
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 2
- YLPKUPIZOXNPSS-UHFFFAOYSA-N OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F Chemical compound OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F YLPKUPIZOXNPSS-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- YOALFLHFSFEMLP-UHFFFAOYSA-N azane;2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluorooctanoic acid Chemical compound [NH4+].[O-]C(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F YOALFLHFSFEMLP-UHFFFAOYSA-N 0.000 description 2
- 108091008324 binding proteins Proteins 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 229960002061 ergocalciferol Drugs 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 238000002161 passivation Methods 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000001892 vitamin D2 Nutrition 0.000 description 2
- 239000011647 vitamin D3 Substances 0.000 description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 2
- BCHIXGBGRHLSBE-UHFFFAOYSA-N (4-methyl-2-oxochromen-7-yl) dihydrogen phosphate Chemical compound C1=C(OP(O)(O)=O)C=CC2=C1OC(=O)C=C2C BCHIXGBGRHLSBE-UHFFFAOYSA-N 0.000 description 1
- FCKJYANJHNLEEP-OIMXRAFZSA-N 24,25-Dihydroxyvitamin D Chemical group C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCC(O)C(C)(C)O)C)=C\C=C1\C[C@H](O)CCC1=C FCKJYANJHNLEEP-OIMXRAFZSA-N 0.000 description 1
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 208000037147 Hypercalcaemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 239000007987 MES buffer Substances 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 108010053210 Phycocyanin Proteins 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 206010047626 Vitamin D Deficiency Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 238000010420 art technique Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000018678 bone mineralization Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- ABDBNWQRPYOPDF-UHFFFAOYSA-N carbonofluoridic acid Chemical class OC(F)=O ABDBNWQRPYOPDF-UHFFFAOYSA-N 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- UQSQSQZYBQSBJZ-UHFFFAOYSA-N fluorosulfonic acid Chemical class OS(F)(=O)=O UQSQSQZYBQSBJZ-UHFFFAOYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000000148 hypercalcaemia Effects 0.000 description 1
- 208000030915 hypercalcemia disease Diseases 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 229940127121 immunoconjugate Drugs 0.000 description 1
- 238000010324 immunological assay Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000008040 ionic compounds Chemical class 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 208000005368 osteomalacia Diseases 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1358940 | 2013-09-17 | ||
| FR1358940 | 2013-09-17 | ||
| PCT/FR2014/052296 WO2015040319A1 (fr) | 2013-09-17 | 2014-09-16 | Solution de dissociation de la vitamine d de sa protéine de liaison, procédé de détection associé et utilisation |
| CN201480051176.8A CN105556313B (zh) | 2013-09-17 | 2014-09-16 | 用于从维生素d结合蛋白解离维生素d的溶液、相关的检测方法及用途 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201480051176.8A Division CN105556313B (zh) | 2013-09-17 | 2014-09-16 | 用于从维生素d结合蛋白解离维生素d的溶液、相关的检测方法及用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN108872614A CN108872614A (zh) | 2018-11-23 |
| CN108872614B true CN108872614B (zh) | 2022-06-21 |
Family
ID=49484364
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810816766.5A Active CN108872614B (zh) | 2013-09-17 | 2014-09-16 | 用于从维生素d结合蛋白解离维生素d的溶液、相关的检测方法及用途 |
| CN201480051176.8A Active CN105556313B (zh) | 2013-09-17 | 2014-09-16 | 用于从维生素d结合蛋白解离维生素d的溶液、相关的检测方法及用途 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201480051176.8A Active CN105556313B (zh) | 2013-09-17 | 2014-09-16 | 用于从维生素d结合蛋白解离维生素d的溶液、相关的检测方法及用途 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10222389B2 (https=) |
| EP (2) | EP3047283B1 (https=) |
| JP (2) | JP6571666B2 (https=) |
| CN (2) | CN108872614B (https=) |
| AU (1) | AU2014322925B2 (https=) |
| BR (1) | BR112016004161B1 (https=) |
| PL (2) | PL3358356T3 (https=) |
| WO (1) | WO2015040319A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112016004161B1 (pt) * | 2013-09-17 | 2023-01-17 | Biomerieux | Uso de pelo menos um tensoativo de fluoroalquila |
| US10852310B2 (en) | 2015-12-11 | 2020-12-01 | Opko Diagnostics, Llc | Fluidic systems involving incubation of samples and/or reagents |
| CN106199015B (zh) * | 2016-06-27 | 2018-08-17 | 江苏拜明生物技术有限公司 | 用于血清样品检测的维生素d释放剂、制备方法及应用 |
| FR3067814A1 (fr) * | 2017-06-20 | 2018-12-21 | Biomerieux | Procede d'application, sur un support solide, d'au moins un partenaire de liaison a une molecule |
| CN108089015B (zh) * | 2017-12-18 | 2020-07-24 | 郑州安图生物工程股份有限公司 | 用于检测人血清样品中25羟基维生素d含量的释放剂及其检测方法 |
| AU2019263158B2 (en) * | 2018-04-30 | 2023-12-14 | Leidos, Inc. | An improved low-power mass interrogation system and assay for determining vitamin D levels |
| CN108918848B (zh) * | 2018-05-22 | 2021-09-10 | 德康润生物科技(北京)有限公司 | 维生素d释放剂及其制备方法与应用 |
| CN109738252B (zh) * | 2019-01-23 | 2021-03-09 | 深圳天辰医疗科技有限公司 | 25-羟基-维生素d解离液 |
| CN109696435B (zh) * | 2019-01-25 | 2021-03-09 | 深圳天辰医疗科技有限公司 | 维生素d的测定方法 |
| CN109975559B (zh) * | 2019-04-29 | 2023-07-11 | 厦门稀土材料研究所 | 一种时间分辨荧光定量检测25羟基维生素d的试剂盒及方法 |
| CN110058028B (zh) * | 2019-05-05 | 2021-03-02 | 苏州长光华医生物医学工程有限公司 | 一种24,25-双羟基维生素d免疫检测试剂盒及其应用 |
| WO2021100841A1 (ja) * | 2019-11-22 | 2021-05-27 | 積水メディカル株式会社 | 25ヒドロキシビタミンd測定試薬及び25ヒドロキシビタミンd測定方法 |
| JP7695892B2 (ja) * | 2019-12-11 | 2025-06-19 | キッコーマン株式会社 | 25-ヒドロキシビタミンd3の定量方法、定量用組成物、定量用キット、電極、センサーチップ、及びセンサー |
| CN113884687B (zh) * | 2021-12-08 | 2022-02-11 | 南京岚轩生物科技有限公司 | 用于检测25-羟基维生素d含量的解离剂及其制备方法 |
| CN114011111B (zh) * | 2022-01-05 | 2022-04-01 | 广州科方生物技术股份有限公司 | 用于结合蛋白中萃取维生素的萃取液及其制备方法和应用 |
| CN115112810B (zh) * | 2022-07-08 | 2023-04-14 | 山西尚宁高科技医学检验中心(有限公司) | 一种用于25羟基维生素d检测的样品前处理方法和应用 |
| CN115774111A (zh) * | 2022-12-20 | 2023-03-10 | 江苏拜明生物技术有限公司 | 一种25-羟基维生素d的检测方法及试剂盒 |
| CN118191344B (zh) * | 2024-05-17 | 2024-07-30 | 山东子峰生物技术有限公司 | 一种基于夹心法的25-羟基维生素d量子点荧光检测试剂及其应用 |
| CN118883958B (zh) * | 2024-09-27 | 2024-12-24 | 安徽惠邦生物工程有限公司 | 25-OH-D、P1NP和β-CTX联合检测试剂盒及其制备方法 |
| CN119510784B (zh) * | 2024-11-29 | 2025-12-30 | 美康生物科技股份有限公司 | 一种25羟基维生素d解离液、检测试剂盒及应用 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101273272A (zh) * | 2005-09-29 | 2008-09-24 | 霍夫曼-拉罗奇有限公司 | 维生素d化合物的释放试剂 |
| CN101413944A (zh) * | 2008-10-31 | 2009-04-22 | 江南大学 | 一种全氟辛酸的酶联免疫检测方法 |
| CN102977773A (zh) * | 2012-12-04 | 2013-03-20 | 安徽省宿州市龙华机械制造有限公司 | 一种含聚乙烯醇的改性硅烷化表面处理前处理剂及其制备方法 |
| CN102985826A (zh) * | 2010-04-01 | 2013-03-20 | 未来诊断有限公司 | 游离的维生素d的免疫分析 |
| CN103282390A (zh) * | 2010-12-28 | 2013-09-04 | 未来诊断有限公司 | 对于维生素d的释放剂 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57176536A (en) * | 1981-04-20 | 1982-10-29 | Matsushita Electric Ind Co Ltd | Manufacture for magnetic recording medium |
| GB2166153A (en) * | 1984-10-25 | 1986-04-30 | Procter & Gamble | No-rinse hard surface cleaning composition |
| JPH0615593B2 (ja) * | 1987-01-07 | 1994-03-02 | 工業技術院長 | 含フツ素高分子化合物 |
| CN2049359U (zh) * | 1989-06-11 | 1989-12-13 | 白求恩医科大学 | 活性维生素d检测药盒 |
| FR2710075B1 (fr) | 1993-09-15 | 1995-10-27 | Bio Merieux | Réactif et procédé pour la détection d'une séquence nucléotidique avec amplification de signal. |
| AU7864094A (en) * | 1993-10-18 | 1995-05-08 | Ag Technology Co., Ltd. | Mixed solvent composition |
| JP3638971B2 (ja) * | 1993-10-18 | 2005-04-13 | 旭硝子株式会社 | 洗浄方法 |
| AU763458B2 (en) * | 1998-06-25 | 2003-07-24 | Biomedica Gmbh | Functional vitamin D derivatives and a method for determining 25-hydroxy-vitamin D and 1alpha,25-dihydroxy-vitamin D |
| FR2781802B1 (fr) | 1998-07-31 | 2001-05-11 | Bio Merieux | Derives satures ou insatures de l'abietane, conjugues derives et utilisations dans une composition diagnostique, un reactif et un dispositif |
| JP2002097230A (ja) | 2000-09-22 | 2002-04-02 | Nippon Mektron Ltd | 含フッ素共重合体の製造方法 |
| GB0029729D0 (en) * | 2000-12-06 | 2001-01-17 | Ids Ltd | Method for detection of vitamin D metabolites |
| US7038068B2 (en) * | 2004-03-16 | 2006-05-02 | Hitachi Global Storage Technologies Netherlands B.V. | Method for liquid/liquid extraction of molecular weight fractions of perfluorinated polyethers |
| CN101273062A (zh) | 2005-09-29 | 2008-09-24 | 霍夫曼-拉罗奇有限公司 | 抗25-羟基维生素d的抗体 |
| CN101328216A (zh) * | 2008-07-24 | 2008-12-24 | 江南大学 | 一种全氟辛酸类药物通用人工抗原的合成方法 |
| WO2011112482A2 (en) * | 2010-03-08 | 2011-09-15 | University Of Utah Research Foundation | Polymeric drug delivery conjugates and methods of making and using thereof |
| WO2011150441A1 (en) * | 2010-06-03 | 2011-12-08 | Wholesome Biopharm Pty Ltd | Medical aerosol formulation comprising ribavirin |
| GB201101801D0 (en) * | 2011-02-02 | 2011-03-16 | Axis Shield Diagnostics Ltd | Binding molecule and method for measuring |
| EP2694980B1 (de) * | 2011-04-04 | 2015-08-26 | Immundiagnostik AG | Bestimmung von vitamin-d-metaboliten in trockenblut |
| CN102628872A (zh) * | 2012-03-31 | 2012-08-08 | 广州菲康生物技术有限公司 | 25羟基维生素d检测试剂盒及其制备方法 |
| CN102887972B (zh) * | 2012-09-28 | 2014-07-16 | 中昊晨光化工研究院有限公司 | 一种三元共聚聚四氟乙烯树脂、其制备方法和其浓缩分散液 |
| BR112016004161B1 (pt) * | 2013-09-17 | 2023-01-17 | Biomerieux | Uso de pelo menos um tensoativo de fluoroalquila |
-
2014
- 2014-09-16 BR BR112016004161-5A patent/BR112016004161B1/pt active IP Right Grant
- 2014-09-16 WO PCT/FR2014/052296 patent/WO2015040319A1/fr not_active Ceased
- 2014-09-16 US US14/915,325 patent/US10222389B2/en active Active
- 2014-09-16 PL PL18163737T patent/PL3358356T3/pl unknown
- 2014-09-16 EP EP14784295.9A patent/EP3047283B1/fr active Active
- 2014-09-16 AU AU2014322925A patent/AU2014322925B2/en active Active
- 2014-09-16 CN CN201810816766.5A patent/CN108872614B/zh active Active
- 2014-09-16 CN CN201480051176.8A patent/CN105556313B/zh active Active
- 2014-09-16 PL PL14784295T patent/PL3047283T3/pl unknown
- 2014-09-16 EP EP18163737.2A patent/EP3358356B1/fr active Active
- 2014-09-16 JP JP2016543445A patent/JP6571666B2/ja active Active
-
2019
- 2019-01-07 US US16/240,904 patent/US11268968B2/en active Active
- 2019-05-08 JP JP2019088404A patent/JP6750066B2/ja active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101273272A (zh) * | 2005-09-29 | 2008-09-24 | 霍夫曼-拉罗奇有限公司 | 维生素d化合物的释放试剂 |
| CN101413944A (zh) * | 2008-10-31 | 2009-04-22 | 江南大学 | 一种全氟辛酸的酶联免疫检测方法 |
| CN102985826A (zh) * | 2010-04-01 | 2013-03-20 | 未来诊断有限公司 | 游离的维生素d的免疫分析 |
| CN103282390A (zh) * | 2010-12-28 | 2013-09-04 | 未来诊断有限公司 | 对于维生素d的释放剂 |
| CN102977773A (zh) * | 2012-12-04 | 2013-03-20 | 安徽省宿州市龙华机械制造有限公司 | 一种含聚乙烯醇的改性硅烷化表面处理前处理剂及其制备方法 |
Non-Patent Citations (2)
| Title |
|---|
| Effects of Monovalent Cations on the Competitive Adsorption of Perfluoroalkyl Acids by Kaolinite: Experimental Studies and Modeling;Feng Xiao等;《Environ Sci Technol》;20111010;第45卷;第10029页左侧第3段,右侧第1段,第S17页第1段 * |
| 液相色谱-串联质谱法测定葡萄酒中7种生物胺含量;孙骥,等;《理化检验-化学分册》;20130630;第49卷(第6期);第698页第1.2节 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105556313A (zh) | 2016-05-04 |
| EP3047283B1 (fr) | 2018-04-18 |
| AU2014322925A1 (en) | 2016-03-17 |
| BR112016004161A2 (https=) | 2017-08-01 |
| JP6750066B2 (ja) | 2020-09-02 |
| US10222389B2 (en) | 2019-03-05 |
| AU2014322925A8 (en) | 2016-03-24 |
| EP3047283A1 (fr) | 2016-07-27 |
| CN108872614A (zh) | 2018-11-23 |
| PL3358356T3 (pl) | 2021-03-08 |
| EP3358356A1 (fr) | 2018-08-08 |
| JP2016531306A (ja) | 2016-10-06 |
| EP3358356B1 (fr) | 2020-09-09 |
| CN105556313B (zh) | 2018-08-24 |
| US11268968B2 (en) | 2022-03-08 |
| AU2014322925B2 (en) | 2020-07-02 |
| US20160202276A1 (en) | 2016-07-14 |
| US20190137524A1 (en) | 2019-05-09 |
| PL3047283T3 (pl) | 2018-10-31 |
| JP2019152674A (ja) | 2019-09-12 |
| JP6571666B2 (ja) | 2019-09-04 |
| BR112016004161B1 (pt) | 2023-01-17 |
| WO2015040319A1 (fr) | 2015-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108872614B (zh) | 用于从维生素d结合蛋白解离维生素d的溶液、相关的检测方法及用途 | |
| US11536717B2 (en) | Method of agglutination immunoassay | |
| US20220365103A1 (en) | Methods and compositions for assaying vitamin d | |
| JP7345002B2 (ja) | 腫瘍マーカーの測定方法及び測定試薬 | |
| CN108362688A (zh) | 一种25羟基维生素d磁微粒化学发光检测试剂盒 | |
| CN108444988B (zh) | 甲状腺球蛋白化学发光检测试剂盒 | |
| US9638696B2 (en) | Process for detection and optional quantification of an analyte | |
| CN117110613A (zh) | 诊断试剂盒及LMWK-Fc在制备肝纤维化诊断试剂中的应用 | |
| WO2015116961A1 (en) | Methods and compositions for assaying vitamin d | |
| CN114324865A (zh) | 一种肌酸激酶同工酶检测试剂盒的制备方法及应用 | |
| CN106990057A (zh) | 一种检测5‑羟吲哚乙酸试剂及制备方法 | |
| CN115902201A (zh) | 尿液中结合珠蛋白含量检测的化学发光免疫分析试剂盒及其分析方法 | |
| CN117169509A (zh) | 一种类风湿因子及其亚型的测定试剂盒及其制备方法和检测方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |